2-Ethyl-4,5-dihydro-1-methyl-1H-imidazol | 109152-88-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 亚胺内酰胺
• 英文名称: 2-Ethyl-4,5-dihydro-1-methyl-1H-imidazol
• 英文别名: 1-methyl-2-ethylimidazoline；InChI=1/C6H12N2/c1-3-6-7-4-5-8(6)2/h3-5H2,1-2H；2-ethyl-1-methyl-4,5-dihydroimidazole
• CAS: 109152-88-7
• 化学式: C₆H₁₂N₂
• 分子量: 112.175
• InChiKey: XMWVQAXQVZXGGP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  15.6
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-Ethyl-4,5-dihydro-1-methyl-1H-imidazol 、 3-溴环己烯 以 苯 为溶剂， 反应 16.0h， 以94%的产率得到3-Cyclohex-2-enyl-2-ethyl-1-methyl-4,5-dihydro-3H-imidazol-1-ium; bromide
  参考文献：
  名称：

  Gruseck, Ursula; Heuschmann, Manfred, Chemische Berichte, 1987, vol. 120, p. 2053 - 2064

  摘要：

  DOI：
• 作为产物：
  描述：

  2-乙基-2-咪唑啉 、 碘甲烷 在 sodium iodide 作用下， 生成 2-Ethyl-4,5-dihydro-1-methyl-1H-imidazol
  参考文献：
  名称：

  Gruseck, Ursula; Heuschmann, Manfred, Chemische Berichte, 1987, vol. 120, p. 2053 - 2064

  摘要：

  DOI：

文献信息

• [EN] COMPLEMENT MODULATORS AND RELATED METHODS<br/>[FR] MODULATEURS DU COMPLÉMENT ET PROCÉDÉS ASSOCIÉS
  申请人：RA PHARMACEUTICALS INC

  公开号：WO2020205501A1

  公开（公告）日：2020-10-08

  The present disclosure presents compounds and compositions that interact with complement components. Some compounds inhibit complement activity. Included are small molecule compounds and compositions that function as C5 inhibitor compounds. Methods for inhibiting complement activity and methods of treating complement-related indications with the C5 inhibitor compounds and compositions are provided.

  本公开涉及与补体成分相互作用的化合物和组合物。一些化合物抑制补体活性。包括作为C5抑制剂化合物的小分子化合物和组合物。提供了抑制补体活性的方法以及利用C5抑制剂化合物和组合物治疗与补体相关症状的方法。
• [EN] PYRIDAZINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS<br/>[FR] COMPOSÉS PYRIDAZINE DESTINÉS À LA LUTTE CONTRE LES NUISIBLES INVERTÉBRÉS
  申请人：BASF SE

  公开号：WO2011003793A1

  公开（公告）日：2011-01-13

  The present invention relates to pyridazine compounds of formulae (I) or (II) and the salts and N-oxides thereof, wherein A is a substituted or unsubstituted isoxazole or isothiazole radical; V is C(Rv) or N; W is C(Rw) or N; with the proviso that either V or W is N; Rt, Ru, Rv, Rw are H, halogen, C1-C4-alkyl and the like; X1 is S, O or NR1a, wherein R1a is selected H, C1-C10-alkyl and the like; X2 is OR2a, NR2bR2c, S(O)mR2d, wherein m is 0, 1 or 2, R2a is C1-C4-alkyl, C1-C4-haloalkyl and the like, R2b, R2c are H, C1-C4-alkyl, C1-C4-haloalkyl and the like, or R2b and R2c together with the nitrogen atom to which they are bound form a heterocycle, and R2d is C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl and the like; and R1 is H, CN, C1-C10-alkyl and the like. The present invention further relates to a method for controlling invertebrate pests, to a method for protecting plant propagation material and/or the plants which grow there- from, to plant propagation material, comprising at least one compound according to the present invention, to a method for treating or protecting an animal from infestation or infection by parasites and to an agricultural composition containing at least one compound according to the present invention.

  本发明涉及式（I）或（II）的吡嗪化合物及其盐和N-氧化物，其中A是取代或未取代的异噁唑或异硫唑基团；V是C（Rv）或N；W是C（Rw）或N；但是V或W中的一个是N；Rt，Ru，Rv，Rw是H，卤素，C1-C4烷基等；X1是S，O或NR1a，其中R1a选自H，C1-C10烷基等；X2是OR2a，NR2bR2c，S（O）mR2d，其中m为0，1或2，R2a是C1-C4烷基，C1-C4卤代烷基等，R2b，R2c是H，C1-C4烷基，C1-C4卤代烷基等，或R2b和R2c与它们所连接的氮原子形成杂环，并且R2d是C1-C4烷基，C1-C4卤代烷基，C3-C6环烷基等；R1是H，CN，C1-C10烷基等。本发明还涉及一种控制无脊椎动物害虫的方法，一种保护植物繁殖材料和/或生长在那里的植物的方法，包括至少一种根据本发明的化合物的植物繁殖材料，一种用于治疗或保护动物免受寄生虫侵染或感染的方法以及一种包含至少一种根据本发明的化合物的农业组合物。
• Piperidine Compound and Process for Preparing the Same
  申请人：Miyake Tsutomu

  公开号：US20090005355A1

  公开（公告）日：2009-01-01

  The present invention is to provide a piperidine compound represented by the formula [I]: wherein Ring A is an optionally substituted benzene ring, Ring B is an optionally substituted benzene ring, R 1 is hydrogen atom or a substituent for amino group, R 2 is hydrogen atom, an optionally substituted hydroxyl group, an optionally substituted amino group, an optionally substituted alkyl group, a substituted carbonyl group or a halogen atom, Z is oxygen atom or —N(R 3 )—, R 3 is hydrogen atom or an optionally substituted alkyl group, R 4a and R 4b may be the same or different, and each is hydrogen atom or an optionally substituted alkyl group, or may be bonded to each other at the both ends to form an alkylene group, or a pharmaceutically acceptable salt thereof, which has an excellent tachykinin receptor antagonistic action.

  本发明提供了一种由式[I]表示的哌啶化合物，其中环A是可选取代的苯环，环B是可选取代的苯环，R1是氢原子或氨基基团的取代基，R2是氢原子、可选取代的羟基、可选取代的氨基、可选取代的烷基、取代的羰基或卤素原子，Z是氧原子或-N（R3）-，R3是氢原子或可选取代的烷基，R4a和R4b可以相同也可以不同，每个是氢原子或可选取代的烷基，或者可以在两端结合形成烷基，或其药学上可接受的盐，具有优异的Tachykinin受体拮抗作用。
• Ligands of Integrin Receptors
  申请人：Geneste Herve

  公开号：US20080221082A1

  公开（公告）日：2008-09-11

  The invention relates to the use of cyclic compounds as ligands of integrin receptors, in particular as ligands of the α V β 3 integrin receptor, the novel compounds themselves, their use, and pharmaceutical preparations comprising these compounds.

  本发明涉及将环状化合物用作整合素受体的配体，特别是用作αVβ3整合素受体的配体，以及这些新化合物本身、它们的用途和包含这些化合物的制药制剂。
• Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
  申请人：Connolly Joseph Terrence

  公开号：US20070265446A1

  公开（公告）日：2007-11-15

  Compounds represented by Formula I: which are useful as are alpha-1A/B adrenoceptor antagonists, to methods of treating conditions associated with the activity of alpha-1A/B adrenoceptors, and to methods of making said compounds, wherein Ar, Z, R, R′, R 5 and R 10 are as defined herein.

  公式I所代表的化合物：它们可用作α-1A/B肾上腺素受体拮抗剂，用于治疗与α-1A/B肾上腺素受体活性相关的疾病的方法，以及制备该化合物的方法，其中Ar、Z、R、R′、R5和R10如本文所定义。

表征谱图